Diagnosis of Men-I Syndrome on 68Ga-DOTANOC PET-CT and Role of Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE

How to Cite:Santosh kumar GuptaSuhas SinglaNishikant A DamleKrishankant AgarwalChandersekhar BalDiagnosis of Men-I Syndrome on ⁶⁸Ga-DOTANOC PET-CT and Role of Peptide Receptor Radionuclide Therapy With ¹⁷⁷Lu-DOTATATE.Int J Endocrinol Metab.10(4):629-633.https://doi.org/10.5812/ijem.4313.

Abstract

Abstract:

MEN-I is a rare genetic disorder classically characterized by a predisposition to tumors of the parathyroid glands, anterior pituitary gland, and pancreatic islet cells. We present a case of MEN-I syndrome diagnosed using predominantly nuclear medicine imaging followed by radionuclide therapy, thus emphasizing the role of nuclear imaging in diagnosing and treating MEN-I.

Keywords

Multiple Endocrine Neoplasia-I

Nuclear Imaging

Full Text

Full text is available in PDF

comments

Crossmark

Checking

Share on

Comments

Number of Comments:0

Cited by

Metrics

Get Permission (article level)

Purchasing Reprints

Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here ( https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.

Search Relations

Author(s):

Santosh kumar Gupta:[PubMed][Scholar]
Suhas Singla:[PubMed][Scholar]
Nishikant A Damle:[PubMed][Scholar]
Krishankant Agarwal:[PubMed][Scholar]
Chandersekhar Bal:[PubMed][Scholar]